Rising prevalence of chronic diseases driving the demand for specimen collection cards in the healthcare industry. Increasing focus on early disease detection and diagnosis contributing to the growth of the market. Growing adoption of personalized medicine and point-of-care testing boosting the demand for specimen collection cards.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product Type, Specimen Type, Application, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Ahlstrom-Munksjö, GenoTech Innovations, Biocare Solutions., PolyTech Research Solutions, QIAGEN, CENTOGENE N.V., Innovate Diagnostics Technologies, PerkinElmer, Cytiva (Danaher), ARCHIMED Life Science, FortiusBio, Eastern Business Forms,, DBS System SA, GenTegra LLC |
High cost associated with specimen collection cards and limited reimbursement policies hampering market growth. Lack of awareness about the benefits of specimen collection cards among healthcare providers and patients posing a challenge to market expansion.